Francisco Martínez-Jiménez
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 10%
- Bioinformatics and Genomic Networks 3
- vaccines and immunoinformatics approaches 1
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
-
- Lung Cancer Treatments and Mutations 3
-
- Genomics and Rare Diseases 2
-
- Computational Drug Discovery Methods 3
-
- Immune Cell Function and Interaction 2
- Co-authors
- Abel González-PérezFerran MuiñosNúria López-BigasOriol PichJose BonetLoris MularoniClaudia Arnedo-PacInés Sentís
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Francisco Martínez-Jiménez
13 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 447
- Molecular Biology 740
- Oncology 270
- Pulmonary and Respiratory Medicine 208
- Genetics 156
Countries citing papers authored by Francisco Martínez-Jiménez
This map shows the geographic impact of Francisco Martínez-Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Martínez-Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Martínez-Jiménez more than expected).
Fields of papers citing papers by Francisco Martínez-Jiménez
This network shows the impact of papers produced by Francisco Martínez-Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Martínez-Jiménez. The network helps show where Francisco Martínez-Jiménez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francisco Martínez-Jiménez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 50 | |
| 5 | Pan-cancer whole-genome comparison of primary and metastatic solid tumoursbreakdown → | 2023 | 125 |
| 6 | 2022 | 13 | |
| 7 | 2021 | 63 | |
| 8 | A compendium of mutational cancer driver genesbreakdown → | 2020 | 729 |
| 9 | 2019 | 30 | |
| 10 | 2017 | 13 | |
| 11 | 2015 | 12 | |
| 12 | 2013 | 41 | |
| 13 | 2013 | 32 |
About Francisco Martínez-Jiménez
Francisco Martínez-Jiménez is a scholar working on Cancer Research, Oncology and Computational Theory and Mathematics, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Computational Drug Discovery Methods (3 papers), Bioinformatics and Genomic Networks (3 papers), Lung Cancer Treatments and Mutations (3 papers), Genomics and Rare Diseases (2 papers), Immune Cell Function and Interaction (2 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Cancer Research (447 citations), Molecular Biology (740 citations) and Oncology (270 citations). Francisco Martínez-Jiménez has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Abel González-Pérez, Ferran Muiños, Núria López-Bigas, Oriol Pich, Jose Bonet, Loris Mularoni, Claudia Arnedo-Pac, Inés Sentís, Iker Reyes-Salazar and Jordi Deu-Pons. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.